No doubt, the turbocharging of IP is in the assay matrices of production and potency. It's what separates MSB from Jacko pumping out stem cells churned out of a yoghurt maker in Manila and injecting them into eyeballs and spines for $10k a pop.
For a cell with a complex profile of powerful cascaded MOAs that move beyond the reductio ad absurdum pretence of single action drugs, assay matrices ARE the science behind a marketable product - for trial success, and potency guarantee for national approvals.
No doubt, the turbocharging of IP is in the assay matrices of...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.070(6.45%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $20.88M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 59978 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 34019 | 3 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.070 ( 5.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 3733217 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |